Welcome to our dedicated page for Reliance Global Group SEC filings (Ticker: RELIW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reliance Global Group Inc. filings document material agreements, governance actions, capital-structure matters and shareholder voting results. Recent 8-K reports cover annual meeting outcomes, director elections, auditor ratification, equity incentive plan amendments, settlement agreements related to prior stock purchase transactions, and definitive agreements involving new investment vehicles.
The company's SEC record also includes proxy materials for stockholder meetings and disclosures tied to common stock, warrants, promissory-note arrangements, board review of related-party matters, and subsidiary activity involving EZRA International Group and LifeSci Global Group.
Reliance Global Group, Inc. entered into an at-the-market offering agreement with H.C. Wainwright & Co., LLC allowing it to sell up to 2,026,453 shares of common stock from time to time through Wainwright as sales agent. These sales will be made under Reliance Global’s effective Form S-3 shelf registration statement and a new prospectus supplement, using methods that qualify as an at-the-market offering on Nasdaq or other permitted markets. The company will pay Wainwright a 3.0% commission on gross sales proceeds, reimburse specified legal fees, and has granted Wainwright a 12‑month right of first refusal to act in key future financing or advisory roles.
Reliance Global Group has entered an At The Market (ATM) sales agreement with H.C. Wainwright to sell up to $2,026,453 of common stock, with Wainwright earning a 3.0% commission. The prospectus uses an assumed offering price of $1.02 per share (closing price on August 6, 2025) and also reports a last reported sale price of $1.05 on August 11, 2025.
Recent material actions include a Series J private placement (June 18, 2025) providing pre-funded warrants to purchase 1,488,096 shares at $0.001 and Series J warrants to purchase 2,976,192 shares at $1.43, and issuance of a placement-agent warrant for 104,167 shares at $2.10. The Company closed the sale of Fortman Insurance for $5,000,000 (effective July 1, 2025), classified Fortman assets held for sale totaling $2,299,767 with related liabilities $289,732, and expects an estimated $2.99 million gain in Q3 2025. Proceeds funded Oak Street debt pre-payments of $4,997,292, leaving a net Oak Street balance of $5,374,461.
The balance sheet showed a net tangible book value of $(7,684,198) (approximately $(2.48) per share) as of June 30, 2025; after pro forma adjustments the as-adjusted figure would be about $(0.90) per share, implying an immediate dilution of $1.92 per share for new investors. Outstanding potential dilution includes 3,866,040 warrants and 1,873,259 unvested equity awards. The prospectus highlights standard offering and market risks, including volatility, dilution, and penny stock considerations.